Malignant pleural mesothelioma: incidence, etiology, diagnosis, treatment, and occupational health.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Deutsches Ärzteblatt International

• Publication date

  2013-05-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.3238/arztebl.2013.0319PMID 23720698PMCID PMC3659962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma

  2013cited by this paper
• Pemetrexed in malignant pleural mesothelioma and the clinical outcome

  2012cited by this paper
• Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy’s and St Thomas’ hospitals

  2012cited by this paper
• Mesothelioma not associated with asbestos exposure.

  2012cited by this paper
• Systemic treatment of malignant pleural mesothelioma.

  2012cited by this paper
• Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy

  2012cited by this paper
• Clinical Impact of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma

  2012cited by this paper
• Long-term survival after lung-sparing total pleurectomy for locally advanced (International Mesothelioma Interest Group Stage T3-T4) non-sarcomatoid malignant pleural mesothelioma.

  2012cited by this paper
• Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.

  2012cited by this paper
• Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma.

  2012cited by this paper
• Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy.

  2012cited by this paper
• Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy.

  2011cited by this paper
• Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma

  2011cited by this paper
• Update on Malignant Pleural Mesothelioma

  2011cited by this paper
• Imaging of mesothelioma.

  2011cited by this paper
• Mesothelioma and analysis of tissue fiber content.

  2011cited by this paper
• Pathohistological diagnosis and differential diagnosis.

  2011cited by this paper
• Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.

  2011cited by this paper
• Epidemiology of mesothelioma and historical background.

  2011cited by this paper
• Diagnostik und Begutachtung asbestbedingter Berufskrankheiten

  2011cited by this paper
• Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

  2011cited by this paper
• Asbestos is still with us: Repeat call for a universal ban.

  2011cited by this paper
• Surgical therapy of mesothelioma.

  2011cited by this paper
• Chemotherapy and radiotherapy for mesothelioma.

  2011cited by this paper
• Tumor Type Influences the Effectiveness of Pleurodesis in Malignant Effusions

  2011cited by this paper
• Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma

  2010cited by this paper
• Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010

  2010cited by this paper
• The possibilities and limitations of direct digital radiography, ultrasound and computed tomography in diagnosing pleural mesotelioma.

  2010cited by this paper
• Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial

  2010cited by this paper
• Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos.

  2010cited by this paper
• Projection of mesothelioma mortality in Britain using Bayesian methods

  2010cited by this paper
• Sonografie der Pleura

  2010cited by this paper
• Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

  2009cited by this paper
• Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

  2009cited by this paper
• Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.

  2009cited by this paper
• Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group.

  2009cited by this paper
• Patterns of Local and Nodal Failure in Malignant Pleural Mesothelioma After Extrapleural Pneumonectomy and Photon-Electron Radiotherapy

  2009cited by this paper
• Mesothelioma Risk and Environmental Exposure to Asbestos: Past and Future Trends in Japan

  2009cited by this paper
• Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure

  2009cited by this paper
• Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.

  2008cited by this paper
• Malignant pleural mesothelioma: surgical management in 285 patients.

  2008cited by this paper
• Radical surgery for malignant pleural mesothelioma: results and prognosis.

  2008cited by this paper
• Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.

  2008cited by this paper
• [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].

  2008cited by this paper
• Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine: A Phase II Study

  2008cited by this paper
• The comparative accuracy of different pleural biopsy techniques in the diagnosis of malignant mesothelioma

  2008cited by this paper
• The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma.

  2008cited by this paper
• Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

  2008cited by this paper
• Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial

  2008cited by this paper
• Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.

  2007cited by this paper
• Mesothelioma mortality in men: trends during 1977–2001 and projections for 2002–2016 in Spain

  2007cited by this paper
• Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.

  2007cited by this paper
• A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005 A single institution experience.

  2007cited by this paper
• Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).

  2007cited by this paper
• Incidence and Descriptive Epidemiology of Mesothelioma in the United States, 1999–2002

  2007cited by this paper
• Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma.

  2005cited by this paper
• Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary.

  2005cited by this paper
• Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.

  2005cited by this paper
• Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma.

  2005cited by this paper
• Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.

  2005cited by this paper
• Mesotheliome bei Akademikern

  2003cited by this paper
• Update of predictions of mortality from pleural mesothelioma in the Netherlands

  2003cited by this paper
• The management of malignant pleural mesothelioma.

  2003cited by this paper
• Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

  2003cited by this paper
• [Mesotheliomas in academics. German mesothelioma register in Bochum].

  2003cited by this paper
• Malignant Mesothelioma in Australia, 1945–2000

  2002cited by this paper
• The management of malignant pleural mesothelioma; single centre experience in 10 years.

  2002cited by this paper
• Malignant mesothelioma in Australia, 1945-2000.

  2002cited by this paper
• A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

  2001cited by this paper
• Malignant mesothelioma – German mesothelioma register 1987–1999

  2001cited by this paper
• Future trends in mortality of French men from mesothelioma

  2000cited by this paper
• Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

  1999cited by this paper
• The European mesothelioma epidemic

  1999cited by this paper
• Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin.

  1999cited by this paper
• Mesothelioma: cases associated with non-occupational and low dose exposures.

  1999cited by this paper
• Pleural mesothelioma: dose-response relation at low levels of asbestos exposure in a French population-based case-control study.

  1998cited by this paper
• Pleurectomy/decortication for palliation in malignant pleural mesothelioma: results of surgery.

  1997cited by this paper
• Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients.

  1996cited by this paper
• RELATION BETWEEN EXPOSURE TO ASBESTOS AND MESOTHELIOMA.

  1965cited by this paper
• Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province

  1960cited by this paper

• Different Diseases, Different Outcomes: A Comparative Study of Peritoneal and Pleural Subtypes.

  2025cites this paper
• Retrospective analysis of mesothelioma cases in a tertiary hospital in Northern Portugal (1988–2023): An epidemiological perspective

  2025cites this paper
• An Overview of Cellular and Molecular Determinants Regulating Chemoresistance in Pleural Mesothelioma

  2025cites this paper
• A Retrospective Epidemiological Study of Mesothelioma in the United States (1999-2020) Based on Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) Data

  2025cites this paper
• Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies.

  2025cites this paper
• Pleural Mesothelioma Diagnosis for the Pulmonologist: Steps Along the Way

  2025cites this paper
• Estrategia de priorización de peligrosidad de productos químicos

  2025cites this paper
• Health inequality and the global burden of mesothelioma: insights from the global burden of disease study 2021

  2025cites this paper
• Fibroblast Activation Protein–Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial

  2024cites this paper
• Is extereme cytoreductive surgery beneficial to survival ın malignant peritoneal mesothelioma?

  2024cites this paper
• Efficacious Factors in Pleural Malignancy Based on Characteristics of Pleural Fluid and Type of Primary Tumor in Shahid Sadouqhi and Shahid Rahmonun Hospitals of Yazd from 2019 to 2021

  2024cites this paper
• Case Report: A case of primary pericardial mesothelioma treated with multimodal combined therapy

  2024cites this paper
• The aftermath of asbestos prohibition in industry and its association with malignant mesothelioma in the south of Iran: An enduring predicament yet to be resolved

  2024cites this paper
• Rare Presentation of Pleural Mesothelioma with Associated Dysphagia in an Elderly Female Cement Trader and the Resultant Diagnostic Challenges: A Case Report

  2023cites this paper
• Interdisziplinäre Diagnostik und Therapie von malignen Mesotheliomen

  2023cites this paper
• The Predictive Value of ERCC1, RRM1, and Thymidylate Synthase in Advanced Malignant Pleural Mesothelioma Patients Treated with Platinum-Based Chemotherapy

  2023cites this paper
• Interdisziplinäre Diagnostik und Therapie von malignen Mesotheliomen

  2023cites this paper
• BMP and activin membrane-bound inhibitor regulate connective tissue growth factor controlling mesothelioma cell proliferation

  2022cites this paper
• Novel 3D organotypic co-culture model of pleura

  2022cites this paper
• The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling

  2022cites this paper
• Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research

  2022cites this paper
• Minimally important differences of EORTC QLQ-C30 scales in patients with lung cancer or malignant pleural mesothelioma - Interpretation guidance derived from two randomized EORTC trials.

  2022cites this paper
• Increased Risk of Gastric Cancer in Asbestos-Exposed Workers: A Retrospective Cohort Study Based on Taiwan Cancer Registry 1980–2015

  2021cites this paper
• Cytological Diagnostic Procedures in Malignant Mesothelioma.

  2021cites this paper
• DNA methylation as a diagnostic biomarker for malignant mesothelioma: a systematic review and meta-analysis.

  2021cites this paper
• Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity

  2021cites this paper
• Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

  2021cites this paper
• Correlation of methylthioadenosine phosphorylase (MTAP) protein expression with MTAP and CDKN2A copy number in malignant pleural mesothelioma

  2021cites this paper
• Odors and cancer: Current status and future directions.

  2021cites this paper
• Conspicuity of malignant pleural mesothelioma in contrast enhanced MDCT – arterial phase or late phase?

  2021influential citation
• The Role of CRS and HIPEC in the Management of Diffuse Malignant Peritoneal Mesothelioma (DMPM)

  2021cites this paper
• Occurrence of asbestos-related occupational diseases in the Czech Republic in the last 20 years.

  2020cites this paper
• Diagnosis of Mesothelioma.

  2020cites this paper
• [Five Years PLEURATUMOR Register of the German Society of Thoracic Surgery].

  2020cites this paper
• Gender differences in molecular‐guided therapy recommendations for metastatic malignant mesothelioma

  2020cites this paper
• Malignes Mesotheliom: Die diagnostische Aussagekraft einer Computertomographie kritisch hinterfragen

  2020cites this paper
• A phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma

  2020cites this paper
• Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance status.

  2020cites this paper
• Fünf Jahre PLEURATUMOR-Register der Deutschen Gesellschaft für Thoraxchirurgie

  2020influential citation
• Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use

  2020cites this paper
• Mesothelioma Mortality Rates in Greece for the Period 2005–2015 Is Increased Compared to Previous Decades

  2019cites this paper
• PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

  2019cites this paper
• Mesothelioma

  2019cites this paper
• Treatment and Outcomes of Primary Pericardial Mesothelioma: A Contemporary Review of 103 Published Cases

  2019cites this paper
• Tratamento Quimioterápico do Mesotelioma Pleural Maligno: Revisão Sistemática

  2019influential citation
• Multimodality Imaging Assessment of Malignant Pleural Mesothelioma

  2019cites this paper
• Mesothelium and Malignant Mesothelioma

  2019cites this paper
• Risk factors and biomarkers for malignant mesothelioma

  2019cites this paper
• Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan

  2018cites this paper
• Ambient Asbestos Fiber Concentrations and Long‐Term Trends in Pleural Mesothelioma Incidence between Urban and Rural Areas in the United States (1973–2012)

  2018cites this paper
• Malignant pleural mesothelioma: diagnostic value of medical thoracoscopy and long-term prognostic analysis

  2018cites this paper
• Process analysis of carcinogenesis: concept derivation of the tissue function “preservation of a homogeneous gene expression”

  2018influential citation
• Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma

  2018cites this paper
• Mortality in a cohort of asbestos-exposed workers undergoing health surveillance

  2018cites this paper
• Variation in incidence trends of malignant pleural mesothelioma in Europe

  2018cites this paper
• Malignant pleural mesothelioma in Finland: regional and gender variation

  2018cites this paper
• Immunotherapy advances for mesothelioma

  2018cites this paper
• Das Deutsche Mesotheliomregister

  2018cites this paper
• Biodistribution and Tumor Uptake of 67Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft

  2018cites this paper
• Case report: Steroid responsive mesothelioma-related pleural effusion

  2018cites this paper
• BAP1 gene mutations in Egyptian patients with advanced sporadic malignant pleural mesothelioma (MPM): relation with clinical outcomes and survival.

  2018cites this paper
• Radiation Therapy in Mesothelioma

  2018cites this paper
• Stellenwert von CRS und HIPEC bei Mesotheliom

  2018cites this paper
• Malignant pleural mesothelioma : recognising an unmet need

  2018cites this paper
• Occupational and Environmental Cancer

  2018influential citation
• Current and prospective pharmacotherapies for the treatment of pleural

  2018cites this paper
• Anti-CTLA-4 therapy for malignant mesothelioma.

  2017cites this paper
• Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study

  2017cites this paper
• Effective induction of death in mesothelioma cells with magnetite nanoparticles under an alternating magnetic field.

  2017cites this paper
• Immunotherapy advances for mesothelioma treatment

  2017cites this paper
• Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis.

  2017cites this paper
• Malignant Pleura Mesothelioma: Clinical Perspectives

  2017cites this paper
• Current and prospective pharmacotherapies for the treatment of pleural mesothelioma

  2017influential citation
• Asbestos-Induced Inflammation in Malignant Mesothelioma and Other Lung Diseases

  2017cites this paper
• The role of inflammasomes in asbestos-induced mesothelial to fibroblastic transition

  2017cites this paper
• MONITORAMENTO DO MESOTELIOMA NO SUL DO BRASIL: UMA REALIDADE AINDA A SER ESTUDADA

  2017cites this paper
• Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.

  2017cites this paper
• [Mesothelioma].

  2017cites this paper
• Minimal change disease associated with malignant pleural mesothelioma: case report and review of the literature

  2016cites this paper
• IMPACTO DA EXPOSIÇÃO AO AMIANTO NA SAÚDE DA POPULAÇÃO ADULTA: REVISÃO INTEGRATIVA

  2016cites this paper
• [Pleural mesothelioma mortality in Italy: time series reconstruction (1970-2009) and comparison with incidence (2003-2008)].

  2016cites this paper
• Diffuses malignes Mesotheliom

  2016cites this paper
• Positive TTF-1 Expression in Malignant Mesothelioma: A Case Report

  2016cites this paper
• Krankheitsbilder

  2016cites this paper
• Detection of malignant pleural mesothelioma in exhaled breath by multicapillary column/ion mobility spectrometry (MCC/IMS)

  2016cites this paper
• Risk of second primary cancers after malignant mesothelioma and vice versa.

  2016cites this paper
• Asbestos exposure and mesothelioma incidence and mortality in Bulgaria

  2016cites this paper
• Chromosome nondisjunction during bipolar mitoses of binucleated intermediates promote aneuploidy formation along with multipolar mitoses rather than chromosome loss in micronuclei induced by asbestos

  2016cites this paper
• Metformin and survival of people with type 2 diabetes and pleural mesothelioma: A population-based retrospective cohort study.

  2016cites this paper
• Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging.

  2016cites this paper
• Renal cell carcinoma and malignant peritoneal mesothelioma after occupational asbestos exposure: case report.

  2016cites this paper
• Prophylactic Radiotherapy to Intervention Sites in Malignant Pleural Mesothelioma--Single-institution Experience and Literature Review.

  2015cites this paper
• Diffuses malignes Mesotheliom

  2015cites this paper
• Benigne und maligne Pleuraerkrankungen

  2015cites this paper
• Asbestos in Asia

  2015cites this paper
• CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion

  2015cites this paper
• Advances in the diagnosis, treatment and prognosis of malignant pleural mesothelioma.

  2015cites this paper
• Asbestosis in a Japanese Macaque (Macaca fuscata)

  2015cites this paper
• Benigne und maligne Pleuraerkrankungen

  2015cites this paper
• Characterization of Mesothelioma Stem Cells, Their Metabolic Signature and Susceptibility to Selected Mitocans

  2015cites this paper